1. Tholen, Jonas, Razew, Michal, Weis, Felix, Galej, Wojciech P. 2021. Structural basis of branch site recognition by the human spliceosome. In Science (New York, N.Y.), 375, 50-57. doi:10.1126/science.abm4245. https://pubmed.ncbi.nlm.nih.gov/34822310/
2. Li, Jinglei, Tong, Hanxing, Li, Dongping, Zhang, Si, Xue, Ruyi. 2021. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC. In Molecular medicine (Cambridge, Mass.), 27, 95. doi:10.1186/s10020-021-00347-7. https://pubmed.ncbi.nlm.nih.gov/34470609/
3. Wu, Yadong, Liu, Feng, Luo, Siyang, Yue, Zhaohui, Song, Jukun. 2019. Co-expression of key gene modules and pathways of human breast cancer cell lines. In Bioscience reports, 39, . doi:10.1042/BSR20181925. https://pubmed.ncbi.nlm.nih.gov/31285391/
4. Peng, Yunsong, Wang, Zeng, Cai, Jianyong, Dong, Xiaoqiao, Du, Quan. 2022. GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. In Journal of oncology, 2022, 1930604. doi:10.1155/2022/1930604. https://pubmed.ncbi.nlm.nih.gov/36284636/
5. Siebring-van Olst, Ellen, Blijlevens, Maxime, de Menezes, Renee X, Smit, Egbert F, van Beusechem, Victor W. 2017. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment. In Molecular oncology, 11, 534-551. doi:10.1002/1878-0261.12052. https://pubmed.ncbi.nlm.nih.gov/28296343/